Amgen (AMGN)

$219.19 0.00 (0.00%)

19:34 EDT AMGN Stock Quote Delayed 20 Minutes

Volume:

Previous Close $219.19

Market Cap 145.04B

PE Ratio 69.58

EPS 3.15

Volume (Avg. Vol.)

Day's Range 219.19 - 219.19

52-Week Range 166.30 - 244.99

Dividend & Yield 5.28 (2.41%)

AMGN Stock Predictions, Articles, and Amgen News

From InvestorPlace
From the Web

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor Mar 16, 2020

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

3 Healthcare Stocks Under Pressure from Bernie

By William Roth, InvestorPlace Market Strategist Jan 27, 2020

These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.

3 of the Best Healthcare Stocks to Buy in 2020

By Tyler Craig, Tales of a Technician Jan 2, 2020

Here are three of the best healthcare stocks to buy, as the sector is flashing a 'buy-the-dip' setup to kick off the New Year.

U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020

By InvestorPlace Staff Dec 27, 2019

Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.

Stock Market Today: New Highs; Buy Micron, Nvidia?

By Bret Kenwell, InvestorPlace Contributor Dec 16, 2019

Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.

3 Healthcare Stocks to Buy Before the End of 2019

By Tyler Craig, Tales of a Technician Dec 9, 2019

The year-end success of the healthcare sector has led to several strong stocks to buy. Here are three of the best healthcare stocks to buy.

Compare Brokers

This $2.7 Billion Deal Is a Shot Across the Bow for Big Pharma

By Matt McCall, Editor, MoneyWire Nov 8, 2019

Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.

2020 Election Could Hurt Amgen Stock’s Healthy Dividend

By Dana Blankenhorn, InvestorPlace Contributor Nov 5, 2019

The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.

7 Big Biotech Stocks to Watch

By Chris Lau, InvestorPlace Contributor Sep 27, 2019

Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

4 Biotech Stocks to Buy That Are on the Move

By William Roth, InvestorPlace Market Strategist Aug 27, 2019

Biotech stocks overall are holding up fairly well amid recent market volatility. Look at which four biotech stocks to buy have staying power.

Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?

By Zacks Investment Research Aug 27, 2019

Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.

Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks

By Bret Kenwell, InvestorPlace Contributor Aug 26, 2019

Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.

Compare Brokers

5 Top Stock Trades for Tuesday: NFLX, AMGN, ACB, BMY

By Bret Kenwell, InvestorPlace Contributor Aug 26, 2019

Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.

Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen

By William White, InvestorPlace Writer Aug 26, 2019

Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.

Wednesday’s Vital Data: Amgen, American Airlines and Apple

By Tyler Craig, Tales of a Technician Aug 14, 2019

Options trading was buzzing on Tuesday, with Amgen, American Airlines and Apple all making notable moves. Here are the metrics that matter moving forward.

9 Catalysts That Will Drive Chinese Biotech Stocks Much Higher

By Matt McCall, Editor, MoneyWire Aug 5, 2019

Matt McCall is extremely bullish on China and the big opportunities in several sectors, but Chinese biotech stocks top his list.

5 Stocks to Buy and Keep an Eye on Come Fall

By William Roth, InvestorPlace Market Strategist Jul 31, 2019

Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks. Thus, individual stock price action is uneven with all the focus going to a handful of names posting solid results.